Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Dec. 8, 2014, 75 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $294.00 to $12,417,450.00.

Highlighted Stocks Traded by Insiders:

Miller Energy Resources (MILL) - FREE Research Report

Boruff Scott M, who is Executive Chairman at Miller Energy Resources, sold 696,000 shares at $1.49 on Dec. 8, 2014. Following this transaction, the Executive Chairman owned 3.2 million shares meaning that the stake was reduced by 17.66% with the 696,000-share transaction.

The shares most recently traded at $1.26, down $0.23, or 18.53% since the insider transaction. Historical insider transactions for Miller Energy Resources go as follows:

  • 4-Week # shares bought: 21,696
  • 4-Week # shares sold: 500,000
  • 12-Week # shares bought: 211,196
  • 12-Week # shares sold: 500,000
  • 24-Week # shares bought: 211,196
  • 24-Week # shares sold: 500,000

The average volume for Miller Energy Resources has been 596,300 shares per day over the past 30 days. Miller Energy Resources has a market cap of $75.6 million and is part of the basic materials sector and energy industry. Shares are down 82.67% year-to-date as of the close of trading on Monday.

Miller Energy Resources, Inc., an independent exploration and production company, explores for, develops, and operates oil and gas wells in south-central Alaska and in the Appalachian region of east Tennessee. Currently, there are 4 analysts who rate Miller Energy Resources a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MILL - FREE

TheStreet Quant Ratings rates Miller Energy Resources as a sell. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity, generally disappointing historical performance in the stock itself and feeble growth in its earnings per share. Get the full Miller Energy Resources Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Tempur Sealy International (TPX) - FREE Research Report

Judge Paul R, who is Director at Tempur Sealy International, sold 900 shares at $54.32 on Dec. 8, 2014. Following this transaction, the Director owned 4,390 shares meaning that the stake was reduced by 17.01% with the 900-share transaction.

The shares most recently traded at $53.28, down $1.04, or 1.95% since the insider transaction. Historical insider transactions for Tempur Sealy International go as follows:

  • 4-Week # shares bought: 2,000
  • 4-Week # shares sold: 5,000
  • 12-Week # shares bought: 2,000
  • 12-Week # shares sold: 5,000
  • 24-Week # shares bought: 2,000
  • 24-Week # shares sold: 5,000

The average volume for Tempur Sealy International has been 811,700 shares per day over the past 30 days. Tempur Sealy International has a market cap of $3.3 billion and is part of the consumer goods sector and consumer durables industry. Shares are up 0.13% year-to-date as of the close of trading on Monday.

Tempur Sealy International, Inc. develops, manufactures, markets, and distributes bedding products in North America and internationally. The company provides mattresses, foundations, adjustable bases, and other products, including pillows and other accessories. The company has a P/E ratio of 37.5. Currently, there are 6 analysts who rate Tempur Sealy International a buy, no analysts rate it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on TPX - FREE

TheStreet Quant Ratings rates Tempur Sealy International as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, expanding profit margins and notable return on equity. However, as a counter to these strengths, we also find weaknesses including generally higher debt management risk, weak operating cash flow and feeble growth in the company's earnings per share. Get the full Tempur Sealy International Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Health Care REIT (HCN) - FREE Research Report

Crabtree Michael A, who is Sr. Vice President & Treasurer at Health Care REIT, sold 1,000 shares at $74.76 on Dec. 8, 2014. Following this transaction, the Sr. Vice President & Treasurer owned 46,268 shares meaning that the stake was reduced by 2.12% with the 1,000-share transaction.

The shares most recently traded at $75.54, up $0.78, or 1.03% since the insider transaction. Historical insider transactions for Health Care REIT go as follows:

  • 4-Week # shares bought: 2,400
  • 4-Week # shares sold: 4,286
  • 12-Week # shares bought: 2,400
  • 12-Week # shares sold: 6,786
  • 24-Week # shares bought: 2,400
  • 24-Week # shares sold: 18,377

The average volume for Health Care REIT has been 2.4 million shares per day over the past 30 days. Health Care REIT has a market cap of $24.2 billion and is part of the financial sector and real estate industry. Shares are up 39.57% year-to-date as of the close of trading on Monday.

Health Care REIT, Inc. is an independent equity real estate investment trust. The firm engages in acquiring, planning, developing, managing, repositioning and monetizing of real estate assets. It primarily invests in the real estate markets of the United States. The stock currently has a dividend yield of 4.3%. The company has a P/E ratio of 82.2. Currently, there are 6 analysts who rate Health Care REIT a buy, 2 analysts rate it a sell, and 6 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on HCN - FREE

TheStreet Quant Ratings rates Health Care REIT as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, compelling growth in net income, revenue growth, reasonable valuation levels and good cash flow from operations. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full Health Care REIT Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null